Table 3 |
||||||||
|
Discordance of QTF and TST results in each group, excluding patients with indeterminate QTF results |
||||||||
|
RA-TNF1 (n = 36) |
RA-TNF2 (n = 38) |
TNF-naive RA (n = 39) |
TB (n = 28) |
LEPROSY (n = 22) |
Healthy controls (n = 41) |
Total (n = 204) |
||
|
|
||||||||
|
QTF (+) |
TST (+) |
5 (13%) |
9 (24%) |
15 (38%) |
12 (40%) |
12 (52%) |
16 (39%) |
69 (34%) |
|
TST (-) |
8 (21%) |
7 (18%) |
5 (13%) |
3 (10%) |
2 (9%) |
3 (7%) |
28 (14%) |
|
|
QTF (-) |
TST (+) |
4 (11%) |
5 (13%) |
6 (15%) |
3 (10%) |
1 (4%) |
12 (29%) |
31 (15%) |
|
TST (-) |
19 (50%) |
17 (45%) |
13 (33%) |
10 (33%) |
7 (30%) |
10 (24%) |
76 (36%) |
|
|
|
||||||||
|
Tuberculin skin test (TST) positivity is defined as an induration of ≥ 10 mm. |
||||||||
|
Hatemi et al. Arthritis Research & Therapy 2012 14:R147 doi:10.1186/ar3882 |
||||||||